THE PATENTS
1) Yale's Bb Flagellin Patent,
5.618,533 94.4% accurate,
earliest, and 100% specific. Or is the best test for Lyme-
The Yale report that goes with the patent (1991):
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1894359&query_hl=2&itool=pubmed_docsum
2)
Yale's LYMErix Patent,
5,747,294, Yes I know these by heart
3)
Padula, UCONN,
5,620,862 Low or No OspC.
"In another aspect of the invention, Northern blot analysis was used to
detect low levels of OspC mRNA in the North American strain B31. DNA sequencing
of the OspC gene from B31 revealed a 54 bp deletion in the upstream regulatory
region, possibly accounting for the low transcriptional activity of OspC."
4)
Barbour and "Immune System Overhwhelmed," US Patent
6,719,983-
"2.1 Methods of Treatment
"An important aspect of the invention is the recognition that Borrelia VMP-like
sequences recombine at the vls site, with the result that antigenic variation is
virtually limitless. Multiclonal populations therefore can exist in an infected
patient so that immunological defenses are severely tested if not totally
overwhelmed."
That means the Yale/Steere/Dearborn method is useless.
5)
Tufts, Huber,
6,689,364
"The present invention provides novel polypeptides which are substantially
free of a B. burgdorferi spirochete or fragments thereof and which are thus
useful in compositions and methods for the treatment and prevention of B.
burgdorferi infection and Lyme disease. In one preferred embodiment, this
invention provides modified OspA polypeptides and pharmaceutically effective
compositions and methods comprising those polypeptides. Preferred modified OspA
polypeptides are characterized by modifications which diminish and/or ablate
their ability to bind the human MHC allele HLA-DRB1*0401."
Means, basically, "superantigen." (Look up what that
means)
6) The RICO Monopoly on testing and LYMErix
The Dave Persing, Mayo Clinic FRAUD Patent-6,045,804 Note the
date on the patent. May, 1996.
Read it. It says they had trouble reading their Western Blots in
1996 in vaccinated people.
Persing, Sigal and Molloy,
2000, and the unreadable blots
Here is
Yale's Robert Schoen
instructing physicians to blow off LYMErix injured persons and not run any tests
on them. This is the 1998 Rahn and Evans textbook Lyme disease, ACP Key Diseases Series. This was published even before LYMErix was
"approved" by the FDA.
The vaccine did not come off the market until Karen Forschner of
the Lyme disease Foundation http://www.lyme.org
demonstrated the Huber Tufts patent above to the FDA and that they KNEW
this vaccine was dangerous.
Schoen also demonstrates that he knows that you
can't use a strain of Bb with the OspA-B plasmid in it, because it causes blot
smudging or IS A SUPERANTIGEN???
FROM LYME_CORRUPTICUT
http://actionlyme.org/LYME_CORRUPTICUT.htm
27) Martin J. Mattessich
President & CEO, Director
“Prior to becoming President
and CEO of Agilix, from 1996 to 1999 Mr. Mattessich was the co-founder of two
Yale University-sponsored biotechnology companies, L2 Diagnostics, LLC
(diagnostic serology) and polyGenomics, Inc. (gene discovery for polygenic
diseases) , and a consultant to CuraGen
Corporation, a publicly held genomics company (pharmaceutical drug ….”
With
the blood he intended to get from the L2 Diagnostics-Imugen nationwide
monopoly on testing, they can identify new diseases to commercialize.
AND genetic susceptibilities to diseases.